The effect of insulin versus pioglitazone treatment on the platelet function in type 2 diabetics

( views:93, downloads:0 )
XIAO Chun-chun(Department of Endocrinology, Anhui Provincial Hospital, Hefei 230001,China)
REN An(Department of Endocrinology, Anhui Provincial Hospital, Hefei 230001,China)
YE Shan-dong(Department of Endocrinology, Anhui Provincial Hospital, Hefei 230001,China)
Journal Title:
Volume 17, Issue 11, 2009
Key Word:
Diabetes;type 2;Insulin;Pioglitazone;Platelet function


  • [1]Sidhu JS,Cowan D,Tooze JA,et al.Peroxisome proliferatoractivated receptor-gamma agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease.Am Heart J,2004,147:E25.
  • [2]Charbonnel B,Matthews DR,Schernthaner G,et al.A long-term comparison of pioglitazone and gliclazide in patients with type 2 diabetes mellitus:a randomized,double-blind,parallel-group comparison trial.Diabet Med,2004,22:399-405.
  • [3]Madonna R,Pandolfi A,Massaro M,et al.Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase.Diabetologia,2004,47:532-536.
  • [4]Marx N,Duez H,Fruchart JC,et al.Peroxisome proliferator-activated receptors and atherogenesis:regulators of gene expression in vascular cells.Circ Res,2004,94:1168-1178.
  • [5]Li D,Chen K,Sinha N,et al.The effects of PPAR-gamma ligand pioglitazone on platelet aggregation and arterial thrombus formation.Cardiovasc Res,2005,65:907-912.
  • [6]Akbiyik F,Ray DM,Gettings KF,et al.Human bone marrow megakaryocytes and platelets express PPARgamma,and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes.Blood,2004,104:1361-1368.
  • [7]Davi G,Catalano I,Averna M,et al.Thromboxane biosynthesis and platelet function in type Ⅱ diabetes mellitus.N Engl J Med,1990,322:1769-1774.
  • [8]Rodier M,Colette C,Gouzes C,et al.Effects of insulin therapy upon plasma lipid fatty acids and platelet aggregation in NIDDM with secondary failure to oral antidiabetic agents.Diabetes Res Clin Pract,1995,28:19-28.
  • [9]Angiolillo DJ,Bernardo E,Ramírez C,et al,Insulin Therapy Is Associated With Platelet Dysfunction in Patients with Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment.J Am Coll Cardiol,2006,48:298-304.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615